Claim 1: an immunogenic composition comprising at least one isolated polypeptide and a pharmaceutically Carrier, where at least a polypeptide selected from the group consisting of: (a) Protein pg0495 P. gingivalis, or an immunogenic fragment or variant of this Protein； (b) u00edna pg0654 of P. gingivalis, or an immunogenic fragment or variant of this Protein pg1374 P.； (c)Gingivalis, or an immunogenic fragment or variant of this； (d) pg1795 Protein of P. gingivalis, or an immunogenic fragment or variant of this Protein pg0613； (e) of P. gingivalis, or an immunogenic fragment or variant of this； (f) of P. gingivalis pg2172 Protein, or a fragment inmunog u00e9ni Co or variant of this Protein pg1326 P.； (g)Gingivalis, or an immunogenic fragment or variant of this Protein pg1798； (H) of P. gingivalis, or an immunogenic fragment or variant of this； I pg0186) Protein of P. gingivalis, or an immunogenic fragment or variant of this； and (j) of P. gingivalis pg0616 Protein, or a fragment inmunog u00e9 Nico or variant of this.Claim 2: an immunogenic composition comprising at least one isolated polypeptide and a pharmaceutically Carrier,Polypeptide with at least one selected from the group consisting of: (a) a polypeptide that has at least 80% identity with the SEQ ID no. 1； (b) a polypeptide that has at least 80% identity with SEQ ID no. 3； (c) a polypeptide that has at least 80% identity with the seq ID no. 5； (d) a polypeptide that has at least 80% identity with SEQ ID no. 7； (e) a polypeptide which has the MEnos 80% identity with SEQ ID no. 9； (f) a polypeptide that has at least 80% identity with SEQ ID no. 11； (g) a polypeptide that has at least 80% identity with SEQ ID no. 13； (H) a polypeptide that has at least 80% identity with SEQ ID no. 15； (i) a polypeptide that you Jan at least 80% identity with SEQ ID no. 17； and (j) a polypeptide that has at least 80% identity.The SEQ ID no. 19.Reivindicación 1: Una composición inmunogénica que comprende al menos un polipéptido
